Arthur M. Cohen & Associates, LLC Agios Pharmaceuticals, Inc. Transaction History

Arthur M. Cohen & Associates, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$33.21 - $46.54 $105,308 - $147,578	-3,171 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$33.87 - $55.93 $107,401 - $177,354	3,171 New	3,171 $111,000
Q2 2019 Jul 29, 2019	SELL	$46.17 - $68.1 $351,446 - $518,377	-7,612 Closed	0 $0
Q3 2014 Nov 08, 2017	BUY	N/A	7,612	7,612 $508,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Arthur M. Cohen & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Arthur M. Cohen & Associates, LLC with notifications on news.